Germany
Japan
United Kingdom
China
Primary Antibodies
Download
Anti-LGR5 mouse mAb, clone OTI2A2, DyLight 488 conjugated
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | DyLight 488 |
Anti-LGR5 mouse mAb, clone OTI2A2, DyLight633 conjugated
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | DyLight 633 |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3C2-4
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 3G11-14
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 4A5-19
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5F4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 5G12-21
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6F5-23
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 6H8-22
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8E8-2
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 8F6-6
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 9G5-20
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 12G4-15
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 15C4-8
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
HER2 (ERBB2) Mouse Monoclonal Antibody, clone 16F12-11
| Applications | FC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 524.00
In Stock
USD 440.00
2 Weeks
Mouse Monoclonal iNOS Antibody (4E5)
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
TA336918 is a replacement of AM06772PU-N.
Mouse monoclonal anti-ATP1A1(NaK ATPase) antibody, clone 464.6, Loading control
| Applications | FC, IHC, WB |
| Reactivities | Canine, Human, Mouse, Porcine, Primate, Rabbit, Rat, Sheep, Xenopus |
| Conjugation | Unconjugated |
Rat Anti-Mouse CD9 Purified (100 ug)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Active filters
Category
- Antibodies
Reactivities
- Mouse
Applications
- FC
Clonalities
- Monoclonal
Filter by
Target Symbol
- ERCC1 (115)
- L1CAM (85)
- CTNNB1 (81)
- ERBB2 (76)
- PNMT (65)
- SENP2 (65)
- PDCD1 (64)
- LGR5 (61)
- ACAT2 (55)
- RNF144B (55)
- TTLL12 (55)
- UBE2E3 (55)
- ZFP36 (55)
- SQSTM1 (53)
- CDK2 (50)
- IGF2BP2 (50)
- KATNB1 (50)
- MAPK7 (50)
- MEIS3 (50)
- MOB3B (50)
- NPR3 (50)
- PACSIN3 (50)
- PFKP (50)
- PRKCE (50)
- RPN1 (50)
- SMS (50)
- BTK (49)
- ACY1 (45)
- AK5 (45)
- ARHGAP25 (45)
- BECN1 (45)
- DSTN (45)
- EPM2AIP1 (45)
- HOXC11 (45)
- LDLRAP1 (45)
- LIMK1 (45)
- NRBP1 (45)
- PDE2A (45)
- PIK3AP1 (45)
- SIRT5 (45)
- SNAP25 (45)
- SNX9 (45)
- SRR (45)
- STAT5A (45)
- TAL1 (45)
- AK4 (40)
- ARFGAP1 (40)
- CHCHD5 (40)
- CRYAB (40)
- DNAJA2 (40)
- ERCC4 (40)
- FBXO21 (40)
- FSHB (40)
- GPHN (40)
- GRHPR (40)
- MSI1 (40)
- NDUFA7 (40)
- PSMC3 (40)
- PTPRE (40)
- SOCS3 (40)
- STAT4 (40)
- SNAI2 (38)
- AKT1 (35)
- ALDH1L1 (35)
- APP (35)
- ATG3 (35)
- CDKN3 (35)
- CHEK2 (35)
- CLPP (35)
- DLD (35)
- DNAJB1 (35)
- DPP3 (35)
- DPP9 (35)
- DYNC1LI1 (35)
- HID1 (35)
- HMOX2 (35)
- LCMT1 (35)
- LHX1 (35)
- MGRN1 (35)
- MIOX (35)
- NGFR (35)
- NUBPL (35)
- OTUB2 (35)
- PLEK (35)
- POR (35)
- PPM1B (35)
- PPP5C (35)
- PRKAR2A (35)
- PRKD2 (35)
- RASD2 (35)
- SNTA1 (35)
- TLE1 (35)
- TOMM34 (35)
- TRIM9 (35)
- ZFAND2B (35)
- AKR1A1 (30)
- AP2M1 (30)
- COMMD1 (30)
- EFNA2 (30)
- ELK3 (30)
Antibody Hosts
Isotypes
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (33)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (15)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created to reduce immunogenicity during in vivo applications. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (5709)
- Transmembrane (1259)
- Transcription Factors (1088)
- Protein Kinase (795)
- Protease (650)
- ES Cell Differentiation/IPS (552)
- Stem cell - Pluripotency (393)
- Secreted Protein (260)
- Phosphatase (197)
- Adult stem cells (134)
- Stem cell relevant signaling - JAK/STAT signaling pathway (84)
- Stem cell relevant signaling - DSL/Notch pathway (83)
- GPCR (76)
- Ion Channels: Other (70)
- P450 (60)
- Embryonic stem cells (31)
- Ion Channels: Potassium (30)
- Cancer stem cells (23)
- Nuclear Hormone Receptor (15)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (14)
- Induced pluripotent stem cells (9)
- Stem cell relevant signaling - Wnt Signaling pathway (4)
Pathways
- Metabolic pathways (1251)
- Pathways in cancer (588)
- Focal adhesion (361)
- Prostate cancer (352)
- MAPK signaling pathway (351)
- Purine metabolism (325)
- Progesterone-mediated oocyte maturation (315)
- Endometrial cancer (273)
- Insulin signaling pathway (273)
- ErbB signaling pathway (269)
- Adherens junction (256)
- Cell cycle (248)
- Neurotrophin signaling pathway (242)
- Tight junction (237)
- Glycolysis / Gluconeogenesis (230)
- Pancreatic cancer (229)
- Colorectal cancer (228)
- Regulation of actin cytoskeleton (228)
- Chronic myeloid leukemia (222)
- Non-small cell lung cancer (217)
- Nucleotide excision repair (216)
- Ubiquitin mediated proteolysis (215)
- Leukocyte transendothelial migration (204)
- Wnt signaling pathway (204)
- Cell adhesion molecules (CAMs) (203)
- Jak-STAT signaling pathway (199)
- Endocytosis (194)
- Axon guidance (191)
- Fc gamma R-mediated phagocytosis (186)
- Fc epsilon RI signaling pathway (185)
- Pyruvate metabolism (185)
- Acute myeloid leukemia (184)
- B cell receptor signaling pathway (184)
- Pathogenic Escherichia coli infection (181)
- Alzheimer's disease (174)
- Bladder cancer (171)
- Small cell lung cancer (168)
- T cell receptor signaling pathway (159)
- Arginine and proline metabolism (156)
- Huntington's disease (153)
- Gap junction (150)
- Oocyte meiosis (146)
- Proteasome (145)
- Renal cell carcinoma (144)
- Thyroid cancer (140)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (138)
- Apoptosis (137)
- Glioma (136)
- Melanoma (136)
- Valine (135)
- Adipocytokine signaling pathway (133)
- Type II diabetes mellitus (133)
- GnRH signaling pathway (126)
- Tyrosine metabolism (125)
- leucine and isoleucine degradation (125)
- mTOR signaling pathway (125)
- Chemokine signaling pathway (117)
- p53 signaling pathway (117)
- Calcium signaling pathway (112)
- Glycine (110)
- serine and threonine metabolism (110)
- Oxidative phosphorylation (106)
- Toll-like receptor signaling pathway (105)
- Parkinson's disease (104)
- Basal cell carcinoma (103)
- Melanogenesis (97)
- Vascular smooth muscle contraction (91)
- Butanoate metabolism (90)
- TGF-beta signaling pathway (87)
- Fructose and mannose metabolism (85)
- VEGF signaling pathway (83)
- Citrate cycle (TCA cycle) (82)
- Regulation of autophagy (82)
- Pentose phosphate pathway (80)
- Epithelial cell signaling in Helicobacter pylori infection (76)
- Fatty acid metabolism (75)
- Glutathione metabolism (75)
- Glyoxylate and dicarboxylate metabolism (75)
- Lysine degradation (75)
- Primary immunodeficiency (75)
- Terpenoid backbone biosynthesis (75)
- Tryptophan metabolism (75)
- Propanoate metabolism (70)
- Synthesis and degradation of ketone bodies (70)
- Cysteine and methionine metabolism (66)
- Porphyrin and chlorophyll metabolism (65)
- Pyrimidine metabolism (65)
- Natural killer cell mediated cytotoxicity (61)
- DNA replication (60)
- Mismatch repair (60)
- Cytokine-cytokine receptor interaction (56)
- Vibrio cholerae infection (56)
- Galactose metabolism (55)
- beta-Alanine metabolism (55)
- Long-term depression (51)
- Notch signaling pathway (51)
- Renin-angiotensin system (51)
- Drug metabolism - cytochrome P450 (50)
- Histidine metabolism (50)
- Inositol phosphate metabolism (50)
- N-Glycan biosynthesis (50)
- RNA degradation (50)
- Glycerolipid metabolism (45)
- Maturity onset diabetes of the young (45)
- Neuroactive ligand-receptor interaction (45)
- Retinol metabolism (45)
- SNARE interactions in vesicular transport (45)
- Amyotrophic lateral sclerosis (ALS) (44)
- Antigen processing and presentation (43)
- Amino sugar and nucleotide sugar metabolism (40)
- Ascorbate and aldarate metabolism (40)
- Hypertrophic cardiomyopathy (HCM) (40)
- One carbon pool by folate (40)
- Dilated cardiomyopathy (38)
- Prion diseases (38)
- Long-term potentiation (36)
- Androgen and estrogen metabolism (35)
- Drug metabolism - other enzymes (35)
- Homologous recombination (35)
- Selenoamino acid metabolism (35)
- Starch and sucrose metabolism (35)
- Hematopoietic cell lineage (34)
- Metabolism of xenobiotics by cytochrome P450 (30)
- Pantothenate and CoA biosynthesis (30)
- Base excision repair (25)
- PPAR signaling pathway (25)
- Complement and coagulation cascades (23)
- Spliceosome (21)
- Alanine (20)
- Arachidonic acid metabolism (20)
- Basal transcription factors (20)
- Caffeine metabolism (20)
- Nicotinate and nicotinamide metabolism (20)
- Vitamin B6 metabolism (20)
- aspartate and glutamate metabolism (20)
- Cardiac muscle contraction (18)
- ABC transporters (17)
- NOD-like receptor signaling pathway (17)
- ECM-receptor interaction (16)
- Circadian rhythm - mammal (15)
- Glycosaminoglycan degradation (15)
- Lysosome (15)
- Methane metabolism (15)
- Phosphatidylinositol signaling system (15)
- Riboflavin metabolism (15)
- Thiamine metabolism (15)
- Viral myocarditis (15)
- Hedgehog signaling pathway (12)
- Phenylalanine metabolism (10)
- leucine and isoleucine biosynthesis (10)
- RIG-I-like receptor signaling pathway (9)
- Systemic lupus erythematosus (9)
- Dorso-ventral axis formation (6)
- Glycosphingolipid biosynthesis - lacto and neolacto series (6)
- Keratan sulfate biosynthesis (5)
- Limonene and pinene degradation (5)
- Nitrogen metabolism (5)
- Olfactory transduction (5)
- RNA polymerase (5)
- Steroid biosynthesis (5)
- Cytosolic DNA-sensing pathway (4)
- Allograft rejection (1)
- Autoimmune thyroid disease (1)
- Graft-versus-host disease (1)
- Type I diabetes mellitus (1)